Correlation Between TC BioPharm and Helius Medical

Can any of the company-specific risk be diversified away by investing in both TC BioPharm and Helius Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining TC BioPharm and Helius Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between TC BioPharm plc and Helius Medical Technologies, you can compare the effects of market volatilities on TC BioPharm and Helius Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in TC BioPharm with a short position of Helius Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of TC BioPharm and Helius Medical.

Diversification Opportunities for TC BioPharm and Helius Medical

-0.22

Correlation Coefficient

TC BioPharm  Helius Medical

Very good diversification

The 3 months correlation between TCBPW and Helius is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding TC BioPharm plc and Helius Medical Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Helius Medical Techn and TC BioPharm is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on TC BioPharm plc are associated (or correlated) with Helius Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Helius Medical Techn has no effect on the direction of TC BioPharm i.e., TC BioPharm and Helius Medical go up and down completely randomly.

Pair Corralation between TC BioPharm and Helius Medical

Assuming the 90 days horizon TC BioPharm plc is expected to generate 10.44 times more return on investment than Helius Medical. However, TC BioPharm is 10.44 times more volatile than Helius Medical Technologies. It trades about 0.11 of its potential returns per unit of risk. Helius Medical Technologies is currently generating about -0.06 per unit of risk. If you would invest  2.50  in TC BioPharm plc on October 4, 2024 and sell it today you would lose (1.38) from holding TC BioPharm plc or give up 55.2% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	88.22%
Values	Daily Returns

TC BioPharm plc  vs.  Helius Medical Technologies

TC BioPharm plc

Risk-Adjusted Performance

3 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in TC BioPharm plc are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, TC BioPharm showed solid returns over the last few months and may actually be approaching a breakup point.

Helius Medical Techn

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Helius Medical Technologies are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady fundamental indicators, Helius Medical unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with TC BioPharm and Helius Medical

The main advantage of trading using opposite TC BioPharm and Helius Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if TC BioPharm position performs unexpectedly, Helius Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Helius Medical will offset losses from the drop in Helius Medical's long position.

The idea behind TC BioPharm plc and Helius Medical Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.